20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler

RxCUI: 759471
RxNorm name: 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Display name: 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Full name: 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RELENZA	ZANAMIVIR	A-S Medication Solutions	b4e68930-4e6d-4d27-b1f0-abf60d12e28d	2026-07-23	Warnings, Adverse reactions	Exact identifier rxcui: 759471
RELENZA	ZANAMIVIR	GlaxoSmithKline LLC	d7c3bcc3-0c0d-4068-fd80-88cf54a376ef	2023-10-24	Warnings, Adverse reactions	Exact identifier rxcui: 759471

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d7c3bcc3-0c0d-4068-fd80-88cf54a376ef	20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler	SCD	33	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir inhalation powder), for oral inhalation use Initial U.S. Approval: 1999	20231024
d7c3bcc3-0c0d-4068-fd80-88cf54a376ef	zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT	SY	33	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir inhalation powder), for oral inhalation use Initial U.S. Approval: 1999	20231024
d7c3bcc3-0c0d-4068-fd80-88cf54a376ef	zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters	PSN	33	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir inhalation powder), for oral inhalation use Initial U.S. Approval: 1999	20231024
12ff22f6-20b5-4fa8-9028-58f87e169ff5	zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters	PSN	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302
12ff22f6-20b5-4fa8-9028-58f87e169ff5	20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler	SCD	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302
12ff22f6-20b5-4fa8-9028-58f87e169ff5	zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT	SY	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302
315556f2-4da0-47fc-86af-8fb61f6dd3bf	zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters	PSN	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302
315556f2-4da0-47fc-86af-8fb61f6dd3bf	zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT	SY	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302
315556f2-4da0-47fc-86af-8fb61f6dd3bf	20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler	SCD	1	These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir) Inhalation Powder, for oral inhalation Initial U.S. Approval: 1999	20100302